PharmaVOICE and ThinkGen
In the first quarter of 2020, more than $788 million was invested in telehealth companies, more than triple the $220 million invested in first-quarter 2019. The COVID-19 pandemic has dramatically reduced in-office medical encounters among both primary providers and specialist caregivers up to 80%. Analysts predict that the number of telehealth consultations will reach 160 million in 2020, reflecting a 700% increase over 2015. To capitalize on the trends leading to virtual care, further investment in technology, processes, and patient education is necessary.